Cigarette smoke induced urocystic epithelial mesenchymal transition via MAPK pathways

Oncotarget. 2017 Jan 31;8(5):8791-8800. doi: 10.18632/oncotarget.14456.

Abstract

Cigarette smoke has been shown to be a major risk factor for bladder cancer. Epithelial-mesenchymal transition (EMT) is a crucial process in cancer development. The role of MAPK pathways in regulating cigarette smoke-triggered urocystic EMT remains to be elucidated. Human normal urothelial cells and BALB/c mice were used as in vitro and in vivo cigarette smoke exposure models. Exposure of human normal urothelial cells to cigarette smoke induced morphological change, enhanced migratory and invasive capacities, reduced epithelial marker expression and increased mesenchymal marker expression, along with the activation of MAPK pathways. Moreover, we revealed that ERK1/2 and p38 inhibitors, but rather JNK inhibitor, effectively attenuated cigarette smoke-induced urocystic EMT. Importantly, the regulatory function of ERK1/2 and p38 pathways in cigarette smoke-triggered urocystic EMT was further confirmed in mice exposed to CS for 12 weeks. These findings could provide new insight into the molecular mechanisms of cigarette smoke-associated bladder cancer development as well as its potential intervention.

Keywords: MAPK pathways; bladder cancer; cigarette smoke; epithelial mesenchymal transition.

MeSH terms

  • Animals
  • Cell Line
  • Cell Movement / drug effects
  • Cell Shape / drug effects
  • Cigarette Smoking / adverse effects*
  • Dose-Response Relationship, Drug
  • Epithelial-Mesenchymal Transition / drug effects*
  • Extracellular Signal-Regulated MAP Kinases / antagonists & inhibitors
  • Extracellular Signal-Regulated MAP Kinases / metabolism*
  • Humans
  • Inhalation Exposure
  • Male
  • Mice, Inbred BALB C
  • Protein Kinase Inhibitors / pharmacology
  • Signal Transduction
  • Smoke / adverse effects*
  • Urinary Bladder / drug effects*
  • Urinary Bladder / enzymology
  • Urinary Bladder / pathology
  • Urothelium / drug effects*
  • Urothelium / enzymology
  • Urothelium / pathology
  • p38 Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • p38 Mitogen-Activated Protein Kinases / metabolism*

Substances

  • Protein Kinase Inhibitors
  • Smoke
  • Extracellular Signal-Regulated MAP Kinases
  • p38 Mitogen-Activated Protein Kinases